| Literature DB >> 30275398 |
Nora Schneider1, Eveline Geiser2, Laura M Gosoniu3, Yulianti Wibowo4, Gertrude Gentile-Rapinett5, Mayke S Tedjasaputra6, Sudigdo Sastroasmoro7.
Abstract
Early childhood nutritional interventions typically combine nutritional and psychosocial stimulation. Such combined interventions result in long-lasting improvements of cognitive abilities in children who are malnourished. Here, we investigated potential cognitive abilities in normally developing children in Indonesia who were, however, at risk for suboptimal cognitive development due to little psychosocial stimulation in their home environment. In a randomized controlled intervention, children of the experimental group received nutritional supplementation combined with cognitive stimulation. Pre- and post-intervention measurements included cognitive development and functioning, behavior, and mother⁻child interaction. The experimental and control group received nutritional supplementation in the form of a fortified or unfortified milk powder, respectively. Additionally, the children and parents of the experimental group jointly engaged in daily learning activities at home and performed iPad-based tasks designed to foster cognitive abilities. The experimental group compared to the control group displayed a significantly higher increase in intelligence quotient as well as a significantly larger reduction in attentional problems after the intervention. These results indicate that low-level cognitive stimulation in combination with nutritional supplementation during early childhood can be an effective intervention that improves global cognitive functioning in healthy developing children. ClinicalTrials.gov Identifier: NCT02359669.Entities:
Keywords: cognitive development; cognitive stimulation; fortification; growing up milk
Mesh:
Year: 2018 PMID: 30275398 PMCID: PMC6213414 DOI: 10.3390/nu10101394
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Composition of fortified milk powder and skimmed milk (control).
| Macronutrients | Unit | Control Product (Skimmed Milk Powder) | Fortified Milk Powder |
|---|---|---|---|
| Energy | kcal/100 g | 467.8 | 477.7 |
| kcal/serving | 168.4 | 172 | |
| Fat | g/100 g | 17.8 | 21.4 |
| g/serving | 6.4 | 7.7 | |
| Alpha-linolenic acid | mg/100 g | 60.9 | 556.6 |
| mg/serving | 28.1 | 200.4 | |
| Protein | g/100 g | 14.8 | 16.3 |
| g/serving | 5.3 | 5.9 | |
| Fortification | mg/100 g | none | Zinc (8), Iron (11.4), Magnesium (141.7), Thiamin (1.05), Niacin (11), Pyridoxine (1.77), Biotin (0.0177), Vitamin C (97.3), and Alpha-linolenic acid (ALA, 556.6) |
Figure 1Design of the randomized intervention study and summary of assessments taken at all time-points and at baseline and V, respectively.
Participant demographics, environmental characteristics, cognitive functioning, and development. Mean and standard deviations are indicated. No significant differences were observed between the two groups (p > 0.05).
| Baseline Measure | Experimental Group ( | Control Group ( |
|---|---|---|
| Age (years) | 3.90 ± 0.57 | 3.93 ± 0.57 |
| Sex (f/m) | 45/60 | 45/52 |
| HOME Inventory (score) | 21.14 ± 3.34 | 21.15 ± 3.25 |
| WPPSI (full-scale IQ score) | 81.64 ± 9.937 | 80.51 ± 10.294 |
| Ages and Stages (above/within normal) | 93/2 | 92/5 |
Participant nutritional status as measured by anthropometric measures (height and weight) at baseline (V0) and V3 indicated separately for gender and experimental group by mean and standard deviation. No significant differences were observed between the two groups at all time-points (p > 0.05).
| Treatment Group | Control Group | |||||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | |||||
| V0 | V3 | V0 | V3 | V0 | V3 | Vo | V3 | |
| Height (cm) | 99.05 ± 6.332 | 102.11 ± 6.429 | 99.54 ± 5.733 | 103.32 ± 5.593 | 100.05 ± 5.151 | 103.67 ± 5.203 | 98.30 ± 5.572 | 101.56 ± 5.400 |
| Weight (kg) | 14.84 ± 2.212 | 15.83 ± 2.797 | 14.92 ± 2.664 | 16.48 ± 2.969 | 15.35 ± 2.047 | 16.39 ± 2.406 | 14.21 ± 2.034 | 15.49 ± 2.231 |
Participant nutritional status at baseline (V0) and V3 as measured by the Hydroxyproline Index in urine samples. Mean and standard deviations are indicated. No significant difference were observed between the two groups at all time-points (p > 0.05).
| Experimental Group | Control Group | |||
|---|---|---|---|---|
| V0 | V3 | V0 | V3 | |
| Hydroxyproline (ug/uL) | 0.1629 ± 0.09821 | 0.6146 ± 0.29840 | 0.1572 ± 0.07314 | 0.6446 ± 0.31704 |
| Creatinine (mg/dL) | 87.49 ± 53.575 | 98.29 ± 46.407 | 86.34 ± 46.975 | 99.30 ± 50.867 |
| Hydroxyproline Index: Hydroxyproline/creatinine (nmol/mg) | 1.48 | 5.0 | 1.51 | 5.2 |
Cognitive stimulation including (a) the use of iPad-based tasks by children of the experimental group as recorded on iPads, (b) the use of paper–pencil learning material (ASQ learning activity) based on parental report, and (c) additional time spent by parents playing with the child outside of experiment-related playing activities based on parental report. Time is indicated for each group of participants between V0 and V3 per day. Mean and standard error are reported. * indicates significance.
| Experimental Group | Control Group | |||
|---|---|---|---|---|
|
Use of iPad-based tasks (minutes/week) | V0 to V1 | 32.9 | - | - |
| V1 to V2 | 34.8 | - | - | |
| V2 to V3 | 29.9 | - | - | |
|
How long | V0 to V1 | 1.26 (0.09) | - | - |
| V1 to V2 | 1.08 (0.07) | - | - | |
| V2 to V3 | 1.43 (1.11) | - | - | |
|
How much longer | V0 to V1 | 2.26 (0.16) | 2.89 (0.21) | |
| V1 to V2 | 1.95 (0.28) | 2.56 (0.21) | ||
| V2 to V3 | 1.54 (0.13) | 2.19 (0.21) |
Figure 2Cognitive and behavioral differences between experimental and control groups expressed as change from baseline after the 6-month intervention. (a) Full-scale IQ composite score and (b) attentional problems are plotted separately for the experimental and the control groups. Error bars reflect standard errors.